Chris is an Executive Partner at Flare Capital Partners.
Dr. Chris Kryder is a proven leader in today’s healthcare information technology arena. Chris served as chairman of Valence Health from 2012 until its acquisition by Evolent Health (NYSE:EVH) in 2016. Previously, he founded and grew D2Hawkeye, selling the company to ISO, which merged its health care Information technology assets to form Verisk Health. He continued to lead the company after it went public as Verisk Analytics (NASDAQ:VRSK). He also co-founded Generation Health, the first Genetic-testing Benefits Manager (GBM), which was later sold to CVS Caremark.
Chris earned his B.A. from the University of Buffalo, his M.D. from Georgetown University, and his MBA from the Massachusetts Institute of Technology. He completed his internal medicine (primary care) medical residency at Harvard, and maintained his primary care medical practice at MIT until the late 1990s. He has been active on the faculty of Harvard Medical School, Division of Health, Science, and Technology for more than 25 years.Back To Team